2020
DOI: 10.1542/peds.2019-0593
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic Performance of C6 Enzyme Immunoassay for Lyme Arthritis

Abstract: OBJECTIVES:In Lyme disease endemic areas, initial management of children with arthritis can be challenging because diagnostic tests take several days to return results, leading to potentially unnecessary invasive procedures. Our objective was to examine the role of the C6 peptide enzyme immunoassay (EIA) test to guide initial management. METHODS:We enrolled children with acute arthritis undergoing evaluation for Lyme disease presenting to a participating Pedi Lyme Net emergency department (2015)(2016)(2017)(20… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 30 publications
0
10
0
Order By: Relevance
“…Presentation with SA is rarer than presentation with LA in areas in which LA is endemic. In a recent study from New England, Nigrovic et al showed that the prevalence of Lyme disease in acute monoarthritis was 23% compared with 1% for SA 21 . In the study by Milewski et al 9 of a group of 391 children presenting ROC curve and corresponding AUC estimate (with 95% CI) for the best diagnostic algorithm to identify LA compared with SA.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Presentation with SA is rarer than presentation with LA in areas in which LA is endemic. In a recent study from New England, Nigrovic et al showed that the prevalence of Lyme disease in acute monoarthritis was 23% compared with 1% for SA 21 . In the study by Milewski et al 9 of a group of 391 children presenting ROC curve and corresponding AUC estimate (with 95% CI) for the best diagnostic algorithm to identify LA compared with SA.…”
Section: Discussionmentioning
confidence: 99%
“…However, these tests can take a considerable amount of time. Nigrovic et al recently reported on the use of a more rapid C6 enzyme immunoassay (EIA) test with a turnaround of a couple of hours, but this still requires validation 21 .…”
Section: Discussionmentioning
confidence: 99%
“…In a recent Pedi Lyme Net study of 911 children with acute arthritis (any joint), none of those with septic arthritis had either a positive or equivocal C6 EIA test. 16 Our septic knee arthritis clinical prediction rule could be used in combination with newer biomarkers as well as the C6 EIA to guide initial patient management.…”
Section: Discussionmentioning
confidence: 99%
“…An additional limitation of the study is the ever-increasing regions where Lyme disease is endemic, making the applicability of this prediction tool less useful over time. However, in non-Lyme endemic areas, were a patient to have a likely exposure to Lyme disease and a concern for septic arthritis, serum sampling for the C6 enzyme immunoassay test should be considered, as a positive or equivocal test result had a high sensitivity (100%) and specificity (94%) for Lyme disease in a multicenter study by Nigrovic et al ( 17 ), and such a result may prevent the unnecessary arthrocentesis.…”
Section: Discussionmentioning
confidence: 99%